0001179110-15-012051.txt : 20150812 0001179110-15-012051.hdr.sgml : 20150812 20150812184608 ACCESSION NUMBER: 0001179110-15-012051 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150810 FILED AS OF DATE: 20150812 DATE AS OF CHANGE: 20150812 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE INC DATE OF NAME CHANGE: 19940719 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JIGANTI JEANINE MARIE CENTRAL INDEX KEY: 0001566865 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 151048275 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 4 1 edgar.xml FORM 4 - X0306 4 2015-08-10 0 0000927066 DAVITA HEALTHCARE PARTNERS INC. DVA 0001566865 JIGANTI JEANINE MARIE 2000 16TH STREET DENVER CO 80202 0 1 0 0 Chief Compliance Officer Common Stock 2015-08-10 4 M 0 938 48.68 A 5000 D Common Stock 2015-08-10 4 F 0 564 81.02 D 4436 D Common Stock 2015-08-10 4 S 0 374 81.5034 D 4062 D Common Stock 2015-08-10 4 S 0 937 81.2421 D 3125 D Stock Appreciation Rights 48.68 2015-08-10 4 M 0 938 0.00 D 2013-07-09 2017-07-09 Common Stock 938 3750 D This amount includes 212 shares acquired under Issuer's employee stock purchase plan on 12/31/2014. Represents the weighted average sale price of $81.2421. The range of prices for the sale of these shares was $81.241 - $81.243, rounded to the nearest thousandths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. The Stock Appreciation Rights were granted on 7/9/2012 and vested 25% on 7/9/2013, then 6.25% every three months thereafter. by Arturo Sida as attorney-in-fact 2015-08-12